TCL Archive FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225. January 4, 2002
TCL Archive FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials. December 22, 2006
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive In Brief: NCI’s George Khoury Dies; Panel to Meet June 22 In Pittsburgh; Rosemary Mackey To Leave MDA May 8, 1987
TCL Archive $14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists October 24, 1996
